Gaia Announces Pricing of Underwritten Public Offering of Common Stock
October 03, 2023 08:00 ET
|
Gaia, Inc.
BOULDER, Colo., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, today announced the pricing of its underwritten public offering of 1,855,000...
Micron Solutions, Inc. Board Announces Proposal for Stock Splits
October 02, 2023 20:16 ET
|
Micron Solutions, Inc.
Micron Solutions, Inc. Board Announces Proposal to Enact Stock Splits in Plan to voluntarily delist from OTC Markets
Brookfield Infrastructure Announces Automatic Purchase Plans
October 02, 2023 17:29 ET
|
Brookfield Infrastructure Partners LP
BROOKFIELD, NEWS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (“BIP”) (NYSE: BIP; TSX: BIP.UN) today announced that, in connection with its previously announced normal...
Gaia Announces Proposed Public Offering of Common Stock
October 02, 2023 17:14 ET
|
Gaia, Inc.
BOULDER, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, announced today that it intends to offer shares of its Class A common stock for...
Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 02, 2023 16:52 ET
|
Immunovant Inc.
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2023 16:27 ET
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically...
Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 02, 2023 16:05 ET
|
Soleno Therapeutics
REDWOOD CITY, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2023 16:05 ET
|
X4 Pharmaceuticals
BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
HANetf ICAV: Notice of Termination of IE000WF4FCJ3
October 02, 2023 12:08 ET
|
HANetf ICAV
DUBLIN, Ireland, Oct. 02, 2023 (GLOBE NEWSWIRE) -- HANetf ICAV(the ICAV) Important Notice to Shareholders of FMQQ Next Frontier Internet & Ecommerce ESG-S UCITS ETF (IE000WF4FCJ3) ...
NYSE Arca Files Form 19b-4 to Convert Grayscale® Ethereum Trust to an ETF
October 02, 2023 08:30 ET
|
Grayscale Investments
STAMFORD, Conn., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Grayscale Investments®, the world’s largest crypto asset manager, today announced that NYSE Arca has filed Form 19b-4 with the Securities and...